The possible role of CD4+CD25highFoxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis

Endocrine

Volumn 50, Issue 3, 2015, Pages 665-673

  Xue, Haibo ^a   Yu, Xiurong ^a   Ma, Lei ^a   Song, Shoujun ^a   Li, Yuanbin ^b   Zhang, Li ^a   Yang, Tingting ^a   Liu, Huan ^a  

^a BINZHOU MEDICAL UNIVERSITY HOSPITAL   (China)

^b Shanxi Dayi Hospital   (China)

Author keywords

Autoimmunity; Hashimoto thyroiditis; Regulatory T cell; T helper 17 cell; Thyroid function

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; AUTOANTIBODY; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; RORC PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CELL POPULATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; STAINING; TH17 CELL; THYROID FUNCTION; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; YOUNG ADULT;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HASHIMOTO DISEASE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84949111993     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0569-y     Document Type: Article

References (42)

1. S.H. Golden, K.A. Robinson, I. Saldanha et al., Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J. Clin. Endocrinol. Metab. 94(6), 1853–1878 (2009)
2. M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525–534 (2010)
3. B. Delemer, J.P. Aubert, P. Nys et al., An observational study of the initial 3212 management of hypothyroidism in France: the ORCHIDEE study. Eur. J. Endocrinol. 167(6), 817–823 (2012)
4. M.P. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99(1), 39–51 (2011)
5. E.N. Pearce, A.P. Farwell, L.E. Braverman, Thyroiditis. N. Engl. J. Med. 348(26), 2646–2655 (2003)
6. D.S. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252–265 (2012)
7. S. Yu, G.C. Sharp, H. Braley-Mullen, Thyrocytes responding to IFN-gamma are essential for development of lymphocytic spontaneous autoimmune thyroiditis and inhibition of thyrocyte hyperplasia. J. Immunol. 176(2), 1259–1265 (2006)
8. S. Koida, K. Tsukasaki, T. Tsuchiya et al., Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis. Haematologica 92(3), e37–40 (2007)
9. H. Qiu, W. Tang, P. Yin et al., Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto’s thyroiditis susceptibility: a meta-analysis. Endocrine 45(2), 198–205 (2014)
10. M. Feng, F.B. Zhang, H.R. Deng, The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto’s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis. Endocrine 44(2), 350–358 (2013)
11. S. Alfadhli, Q. Almutawa, J.M. Abbas et al., Association of Hashimoto’s thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population. Endocrine 43(3), 666–677 (2013)
12. J. Yang, Q. Qin, N. Yan et al., CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41(1), 111–115 (2012)
13. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8–27 (2006)
14. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9(3), 239–244 (2008)
15. J. Zhu, W.E. Paul, CD4 T cells: fates, functions, and faults. Blood 112(5), 1557–1569 (2008)
16. A.B. Glick, A. Wodzinski, P. Fu, A.D. Levine, D.N. Wald, Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 23(7), 871–878 (2013)
17. C.T. Weaver, R.D. Hatton, P.R. Mangan, L.E. Harrington, IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821–852 (2007)
18. E. Bettelli, M. Oukka, V.K. Kuchroo, T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8(4), 345–350 (2007)
19. J. Furuzawa-Carballeda, M.I. Vargas-Rojas, A.R. Cabral, Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6(3), 169–175 (2007)
20. P. Miossec, T. Korn, V.K. Kuchroo, Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361(9), 888–898 (2009)
21. T. Korn, E. Bettelli, M. Oukka, V.K. Kuchroo, IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485–517 (2009)
22. Y. Shi, H. Wang, Z. Su et al., Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand. J. Immunol. 72(3), 250–255 (2010)
23. J.T. Dunn, H.E. Crutchfield, R. Gutekunst, A.D. Dunn, Methods for measuring iodine in urine (International Council for the Control of Deficiency Disorders, Wageningen, 1993)
24. W. Teng, Z. Shan, X. Teng et al., Effect of iodine intake on thyroid diseases in China. N. Engl. J. Med. 354(26), 2783–2793 (2006)
25. I. Raphael, S. Nalawade, T.N. Eagar, T.G. Forsthuber, T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine (2014). doi:10.1016/j.cyto.2014.09.011
26. N. Figueroa-Vega, M. Alfonso-Perez, I. Benedicto et al., Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 95(2), 953–962 (2010)
27. D. Peng, B. Xu, Y. Wang, H. Guo, Y. Jiang, A high frequency of circulating Th22 and Th17 cells in patients with new onset Graves’ disease. PLoS ONE 8(7), e68446 (2013)
28. + regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J. Autoimmun. 33(1), 68–76 (2009)
29. +T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J. Exp. Med. 203(2), 349–358 (2006)
30. J.D. Fontenot, J.P. Rasmussen, L.M. Williams et al., Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22(3), 329–341 (2005)
31. + regulatory T cells. J. Exp. Med. 201(7), 1061–1067 (2005)
32. D. Li, W. Cai, R. Gu et al., Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin. Immunol. 149(3), 411–420 (2013)
33. M. Klatka, E. Grywalska, M. Partyka et al., Th17 and Treg cells in adolescents with Graves’ disease. Impact of treatment with methimazole on these cell subsets. Autoimmunity 47(3), 201–211 (2014)
34. B. Kristensen, L. Hegedüs, H.O. Madsen et al., Altered balance between self-reactive Th17 cells and Th10 cells and between full-length Foxp3 and Foxp3 splice variants in Hashimoto’s thyroiditis. Clin. Exp. Immunol. (2014). doi:10.1111/cei.12557
35. H.G. Evans, T. Suddason, I. Jackson et al., Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104(43), 17034–17039 (2007)
36. E.V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, F. Sallusto, Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8(9), 942–949 (2007)
37. N.J. Wilson, K. Boniface, J.R. Chan et al., Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8(9), 950–957 (2007)
38. L. Zhou, J.E. Lopes, M.M. Chong et al., TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453(7192), 236–240 (2008)
39. K. Ichiyama, H. Yoshida, Y. Wakabayashi et al., Foxp3 inhibits ROR gammat-mediated IL-17 mRNA transcription through direct interaction with ROR gammat. J. Biol. Chem. 283(25), 17003–17008 (2008)
40. L. Shi, M. Bi, R. Yang et al., Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice. J. Endocrinol. Invest. 37(1), 43–50 (2014)
41. P.I. Spuls, L. Hooft, Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal. Br. J. Dermatol. 167(4), 710–713 (2012); discussion 714–715
42. W. Hueber, D.D. Patel, T. Dryja et al., Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. (2010). doi:10.1126/scitranslmed.3001107